Sign up to save your podcasts
Or
Share Episode 16: A Between the Biotech Waves conversation with Abraham Heifets CEO of Atomwise
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 16: A Between the Biotech Waves conversation with Abraham Heifets CEO of Atomwise
Today we talk to Abe Heifets, CEO of Atomwise, a biotech company focusing on the utilization of AI for drug discovery. Atomwise recently (post this recording) announced a $1.2B discovery deal with Sanofi. We discuss AI, its use in drug discovery and development, recent advances and the potential sentient nature of AI. Enjoy.
View all episodes
By Nessan Bermingham PhD
4.9
2121 ratings
Today we talk to Abe Heifets, CEO of Atomwise, a biotech company focusing on the utilization of AI for drug discovery. Atomwise recently (post this recording) announced a $1.2B discovery deal with Sanofi. We discuss AI, its use in drug discovery and development, recent advances and the potential sentient nature of AI. Enjoy.
More shows like Between the Biotech Waves
View all
WSJ What’s News
4,334 Listeners
WSJ Your Money Briefing
1,716 Listeners
Marketplace
8,638 Listeners
Acquired
4,223 Listeners
Odd Lots
1,855 Listeners
Animal Spirits Podcast
2,000 Listeners
The Indicator from Planet Money
9,502 Listeners
The Readout Loud
316 Listeners
The Long View
878 Listeners
Business Of Biotech
88 Listeners
BioCentury This Week
30 Listeners
Raising Health
144 Listeners
Biotech Hangout
18 Listeners
Ground Truths
50 Listeners
Money Stuff: The Podcast
378 Listeners